› Forums › General Melanoma Community › Oncologist to prescribe BRAF and MEK inhibitor
- This topic has 9 replies, 3 voices, and was last updated 12 years, 4 months ago by
awillett1991.
- Post
-
- October 15, 2013 at 6:08 pm
Hi Everyone,
I'm just wondering if anyone knows of an oncologist willing to prescribe a BRAF inhibitor with a MEK inhibitor?
We are located in Canada, but see an oncologist in Michigan as well and are willing to travel within Canada or the U.S. to get it.
thanks
Nikki
- Replies
-
-
- October 15, 2013 at 8:11 pm
Nikki, I'm not comfortable answering the question posed. However, what I can tell you is that I see the melanoma team at the Abramson Center at the University of Pennsylvania in Philadelphia. The care is excellent. As you can see from my other posts, I'm on the GSK combo. I obviously have no insights on whether the doctors at UPenn will generally prescribe the combo, or whether they think it is only appropriate in certain situations. Best of luck.
-
- October 16, 2013 at 5:56 pm
thank you so much for the help. We're waiting to hear back from a couple oncologists in Canada, so fingers crossed. I've looked into the clinical trials for the combo as well, but I don't think he'll qualify as he just finished whole brain radiation and has had systemic therapy with yervoy. He's set to start dabrafenib next week and if we can't get the trametinib with it, we'll hope for the combo approval in January and maybe get it then.
-
- October 17, 2013 at 5:49 pm
I had just tried starting the combo but it is too hard on me so am dropping the MEK because of the side effects. I wish you the best and hope this helps.
Amy
-
- October 17, 2013 at 5:49 pm
I had just tried starting the combo but it is too hard on me so am dropping the MEK because of the side effects. I wish you the best and hope this helps.
Amy
-
- October 17, 2013 at 5:49 pm
I had just tried starting the combo but it is too hard on me so am dropping the MEK because of the side effects. I wish you the best and hope this helps.
Amy
-
- October 16, 2013 at 5:56 pm
thank you so much for the help. We're waiting to hear back from a couple oncologists in Canada, so fingers crossed. I've looked into the clinical trials for the combo as well, but I don't think he'll qualify as he just finished whole brain radiation and has had systemic therapy with yervoy. He's set to start dabrafenib next week and if we can't get the trametinib with it, we'll hope for the combo approval in January and maybe get it then.
-
- October 16, 2013 at 5:56 pm
thank you so much for the help. We're waiting to hear back from a couple oncologists in Canada, so fingers crossed. I've looked into the clinical trials for the combo as well, but I don't think he'll qualify as he just finished whole brain radiation and has had systemic therapy with yervoy. He's set to start dabrafenib next week and if we can't get the trametinib with it, we'll hope for the combo approval in January and maybe get it then.
-
- October 15, 2013 at 8:11 pm
Nikki, I'm not comfortable answering the question posed. However, what I can tell you is that I see the melanoma team at the Abramson Center at the University of Pennsylvania in Philadelphia. The care is excellent. As you can see from my other posts, I'm on the GSK combo. I obviously have no insights on whether the doctors at UPenn will generally prescribe the combo, or whether they think it is only appropriate in certain situations. Best of luck.
-
- October 15, 2013 at 8:11 pm
Nikki, I'm not comfortable answering the question posed. However, what I can tell you is that I see the melanoma team at the Abramson Center at the University of Pennsylvania in Philadelphia. The care is excellent. As you can see from my other posts, I'm on the GSK combo. I obviously have no insights on whether the doctors at UPenn will generally prescribe the combo, or whether they think it is only appropriate in certain situations. Best of luck.
-
- You must be logged in to reply to this topic.